Cancer Vaccine Institute News

We are thrilled to announce that Dr. Natasha Hunter, MD, has been appointed Director of Clinical Trials at the Cancer Vaccine Institute (CVI). Dr. Hunter is a translational breast cancer researcher and clinical oncologist at the University of Washington and Fred Hutchinson Cancer Center. Her research focuses on circulating tumor DNA to guide treatment decisions and monitor disease response, as well as immunologic strategies to detect micrometastatic disease and prevent cancer

We are proud to announce that Dr. Nora Disis, Director of the Cancer Vaccine Institute, has been selected as a 2025 Champion of SITC by the Society for Immunotherapy of Cancer (SITC). This special recognition, part of SITC’s 40th anniversary celebration, honors 40 individuals whose work has significantly advanced the society’s mission—including education, scientific exchange, global access, advocacy, and leadership development. Dr. Disis’ pioneering contributions to cancer va

On the Cancer Research Frontier is a series spotlighting the scientists, doctors, nurses, patients, and philanthropists at the CVI.

The Women’s University Club has selected Dr. Nora Disis , Cancer Vaccine Institute (CVI) Founder and Director, as one of three women in...

CVI Director Dr. Nora Disis was funded $300K to advance the development of a vaccine designed to prevent ovarian cancer’s metastatic spread.